nodes	percent_of_prediction	percent_of_DWPC	metapath
Trovafloxacin—TOP2A—Teniposide—lung cancer	0.415	0.574	CbGbCtD
Trovafloxacin—TOP2A—Etoposide—lung cancer	0.183	0.253	CbGbCtD
Trovafloxacin—TOP2A—Doxorubicin—lung cancer	0.125	0.173	CbGbCtD
Trovafloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—RRAD—lung cancer	0.00233	0.104	CbGpPWpGaD
Trovafloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—AXL—lung cancer	0.00176	0.0786	CbGpPWpGaD
Trovafloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—TP63—lung cancer	0.000978	0.0436	CbGpPWpGaD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—HMGB2—lung cancer	0.000917	0.0408	CbGpPWpGaD
Trovafloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—SFN—lung cancer	0.000834	0.0372	CbGpPWpGaD
Trovafloxacin—TOP2A—Docetaxel—Paclitaxel—lung cancer	0.00073	0.0971	CbGdCrCtD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RRM1—lung cancer	0.000695	0.0309	CbGpPWpGaD
Trovafloxacin—Norfloxacin—CYP2A6—lung cancer	0.000683	0.466	CrCbGaD
Trovafloxacin—TOP2A—Irinotecan—Topotecan—lung cancer	0.000625	0.0831	CbGdCrCtD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MSH6—lung cancer	0.000619	0.0276	CbGpPWpGaD
Trovafloxacin—TOP2A—Erlotinib—Gefitinib—lung cancer	0.000545	0.0725	CbGdCrCtD
Trovafloxacin—TOP2A—Gastric Cancer Network 1—APC—lung cancer	0.000522	0.0232	CbGpPWpGaD
Trovafloxacin—TOP2A—Topotecan—Irinotecan—lung cancer	0.000519	0.069	CbGdCrCtD
Trovafloxacin—TOP2A—Etoposide—Teniposide—lung cancer	0.000516	0.0686	CbGdCrCtD
Trovafloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—lung cancer	0.00048	0.0214	CbGpPWpGaD
Trovafloxacin—Norfloxacin—CYP1A1—lung cancer	0.000479	0.327	CrCbGaD
Trovafloxacin—TOP2A—Circadian rythm related genes—KMT2A—lung cancer	0.000469	0.0209	CbGpPWpGaD
Trovafloxacin—TOP2A—Vindesine—Vinorelbine—lung cancer	0.000465	0.0617	CbGdCrCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TOP1—lung cancer	0.000447	0.0199	CbGpPWpGaD
Trovafloxacin—TOP2A—Circadian rythm related genes—TOP1—lung cancer	0.000429	0.0191	CbGpPWpGaD
Trovafloxacin—TOP2A—Circadian rythm related genes—NKX2-1—lung cancer	0.000418	0.0186	CbGpPWpGaD
Trovafloxacin—TOP2A—Podofilox—Teniposide—lung cancer	0.000394	0.0523	CbGdCrCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RHEB—lung cancer	0.000391	0.0174	CbGpPWpGaD
Trovafloxacin—TOP2A—Vindesine—Vinblastine—lung cancer	0.000371	0.0493	CbGdCrCtD
Trovafloxacin—TOP2A—Methotrexate—Pemetrexed—lung cancer	0.00037	0.0492	CbGdCrCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NODAL—lung cancer	0.00037	0.0165	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RRM1—lung cancer	0.00037	0.0165	CbGpPWpGaD
Trovafloxacin—TOP2A—Paclitaxel—Docetaxel—lung cancer	0.000365	0.0484	CbGdCrCtD
Trovafloxacin—TOP2A—Afatinib—Gefitinib—lung cancer	0.000357	0.0474	CbGdCrCtD
Trovafloxacin—TOP2A—Gefitinib—Erlotinib—lung cancer	0.00035	0.0465	CbGdCrCtD
Trovafloxacin—TOP2A—Mitotic G1-G1/S phases—PPP2R1B—lung cancer	0.00033	0.0147	CbGpPWpGaD
Trovafloxacin—Ciprofloxacin—ABCB1—lung cancer	0.000303	0.207	CrCbGaD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—lung cancer	0.000295	0.0131	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RARB—lung cancer	0.000288	0.0128	CbGpPWpGaD
Trovafloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—lung cancer	0.000288	0.0128	CbGpPWpGaD
Trovafloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—lung cancer	0.000279	0.0124	CbGpPWpGaD
Trovafloxacin—TOP2A—Circadian rythm related genes—AHR—lung cancer	0.000276	0.0123	CbGpPWpGaD
Trovafloxacin—TOP2A—Gastric Cancer Network 2—MYC—lung cancer	0.000272	0.0121	CbGpPWpGaD
Trovafloxacin—TOP2A—Gastric Cancer Network 2—EGFR—lung cancer	0.000266	0.0119	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	0.000252	0.0112	CbGpPWpGaD
Trovafloxacin—TOP2A—Vincristine—Vinorelbine—lung cancer	0.000251	0.0333	CbGdCrCtD
Trovafloxacin—TOP2A—Circadian rythm related genes—ADCY1—lung cancer	0.000246	0.011	CbGpPWpGaD
Trovafloxacin—TOP2A—Vinorelbine—Vinblastine—lung cancer	0.000234	0.0311	CbGdCrCtD
Trovafloxacin—TOP2A—Teniposide—Etoposide—lung cancer	0.000234	0.0311	CbGdCrCtD
Trovafloxacin—TOP2A—Podofilox—Etoposide—lung cancer	0.000234	0.0311	CbGdCrCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	0.000224	0.01	CbGpPWpGaD
Trovafloxacin—TOP2A—Gastric Cancer Network 2—TP53—lung cancer	0.000223	0.00996	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APP—lung cancer	0.000213	0.00948	CbGpPWpGaD
Trovafloxacin—TOP2A—Mitotic G1-G1/S phases—TYMS—lung cancer	0.000208	0.00925	CbGpPWpGaD
Trovafloxacin—TOP2A—Vinblastine—Vinorelbine—lung cancer	0.000202	0.0268	CbGdCrCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	0.000201	0.00897	CbGpPWpGaD
Trovafloxacin—TOP2A—Vincristine—Vinblastine—lung cancer	0.0002	0.0266	CbGdCrCtD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—lung cancer	0.0002	0.00891	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	0.000183	0.00815	CbGpPWpGaD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—lung cancer	0.000171	0.0076	CbGpPWpGaD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—lung cancer	0.00017	0.00757	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—lung cancer	0.00016	0.00714	CbGpPWpGaD
Trovafloxacin—TOP2A—Circadian rythm related genes—AVP—lung cancer	0.000159	0.00707	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	0.000157	0.00701	CbGpPWpGaD
Trovafloxacin—TOP2A—Circadian rythm related genes—TYMS—lung cancer	0.000151	0.00673	CbGpPWpGaD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—lung cancer	0.000149	0.00662	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—FOXM1—lung cancer	0.000146	0.00651	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	0.000145	0.00644	CbGpPWpGaD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—lung cancer	0.000144	0.0064	CbGpPWpGaD
Trovafloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—lung cancer	0.000141	0.00627	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	0.000133	0.00593	CbGpPWpGaD
Trovafloxacin—TOP2A—Cytarabine—Gemcitabine—lung cancer	0.000132	0.0175	CbGdCrCtD
Trovafloxacin—TOP2A—Cell Cycle—FOXM1—lung cancer	0.000131	0.00582	CbGpPWpGaD
Trovafloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—lung cancer	0.000124	0.00551	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—PPP2R1B—lung cancer	0.000121	0.00539	CbGpPWpGaD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—lung cancer	0.000119	0.00531	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—LMNA—lung cancer	0.000116	0.00515	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—lung cancer	0.000115	0.00514	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	0.000114	0.00509	CbGpPWpGaD
Trovafloxacin—TOP2A—Idarubicin—Doxorubicin—lung cancer	0.000113	0.015	CbGdCrCtD
Trovafloxacin—TOP2A—Daunorubicin—Doxorubicin—lung cancer	0.000113	0.015	CbGdCrCtD
Trovafloxacin—TOP2A—Epirubicin—Doxorubicin—lung cancer	0.000113	0.015	CbGdCrCtD
Trovafloxacin—TOP2A—Cell Cycle—PPP2R1B—lung cancer	0.000108	0.00482	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	0.000108	0.00479	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	0.000107	0.00477	CbGpPWpGaD
Trovafloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—lung cancer	0.000105	0.00466	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—LMNA—lung cancer	0.000103	0.0046	CbGpPWpGaD
Trovafloxacin—Hypersensitivity—Irinotecan—lung cancer	0.000102	0.000416	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	0.000102	0.00455	CbGpPWpGaD
Trovafloxacin—Convulsion—Docetaxel—lung cancer	0.000102	0.000415	CcSEcCtD
Trovafloxacin—Paraesthesia—Paclitaxel—lung cancer	0.000102	0.000414	CcSEcCtD
Trovafloxacin—Hypertension—Docetaxel—lung cancer	0.000102	0.000413	CcSEcCtD
Trovafloxacin—Agranulocytosis—Methotrexate—lung cancer	0.000101	0.000412	CcSEcCtD
Trovafloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—lung cancer	0.000101	0.00451	CbGpPWpGaD
Trovafloxacin—Dyspnoea—Paclitaxel—lung cancer	0.000101	0.000411	CcSEcCtD
Trovafloxacin—Somnolence—Paclitaxel—lung cancer	0.000101	0.00041	CcSEcCtD
Trovafloxacin—Decreased appetite—Etoposide—lung cancer	0.0001	0.000408	CcSEcCtD
Trovafloxacin—Myalgia—Docetaxel—lung cancer	0.0001	0.000407	CcSEcCtD
Trovafloxacin—Arthralgia—Docetaxel—lung cancer	0.0001	0.000407	CcSEcCtD
Trovafloxacin—Chest pain—Docetaxel—lung cancer	0.0001	0.000407	CcSEcCtD
Trovafloxacin—Pancytopenia—Doxorubicin—lung cancer	0.0001	0.000407	CcSEcCtD
Trovafloxacin—Nausea—Vinorelbine—lung cancer	0.0001	0.000407	CcSEcCtD
Trovafloxacin—Gastrointestinal disorder—Etoposide—lung cancer	9.98e-05	0.000406	CcSEcCtD
Trovafloxacin—Dyspepsia—Paclitaxel—lung cancer	9.98e-05	0.000406	CcSEcCtD
Trovafloxacin—Body temperature increased—Cisplatin—lung cancer	9.97e-05	0.000405	CcSEcCtD
Trovafloxacin—Asthenia—Irinotecan—lung cancer	9.97e-05	0.000405	CcSEcCtD
Trovafloxacin—Fatigue—Etoposide—lung cancer	9.97e-05	0.000405	CcSEcCtD
Trovafloxacin—Constipation—Etoposide—lung cancer	9.88e-05	0.000402	CcSEcCtD
Trovafloxacin—Pain—Etoposide—lung cancer	9.88e-05	0.000402	CcSEcCtD
Trovafloxacin—Dysuria—Doxorubicin—lung cancer	9.86e-05	0.000401	CcSEcCtD
Trovafloxacin—Decreased appetite—Paclitaxel—lung cancer	9.85e-05	0.0004	CcSEcCtD
Trovafloxacin—Dry mouth—Docetaxel—lung cancer	9.8e-05	0.000398	CcSEcCtD
Trovafloxacin—Upper respiratory tract infection—Doxorubicin—lung cancer	9.8e-05	0.000398	CcSEcCtD
Trovafloxacin—Haemoglobin—Methotrexate—lung cancer	9.8e-05	0.000398	CcSEcCtD
Trovafloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—lung cancer	9.79e-05	0.00436	CbGpPWpGaD
Trovafloxacin—Gastrointestinal disorder—Paclitaxel—lung cancer	9.78e-05	0.000398	CcSEcCtD
Trovafloxacin—Fatigue—Paclitaxel—lung cancer	9.77e-05	0.000397	CcSEcCtD
Trovafloxacin—Haemorrhage—Methotrexate—lung cancer	9.75e-05	0.000396	CcSEcCtD
Trovafloxacin—Hepatitis—Methotrexate—lung cancer	9.75e-05	0.000396	CcSEcCtD
Trovafloxacin—Pollakiuria—Doxorubicin—lung cancer	9.74e-05	0.000396	CcSEcCtD
Trovafloxacin—Asthenia—Gemcitabine—lung cancer	9.71e-05	0.000395	CcSEcCtD
Trovafloxacin—Pain—Paclitaxel—lung cancer	9.69e-05	0.000394	CcSEcCtD
Trovafloxacin—Constipation—Paclitaxel—lung cancer	9.69e-05	0.000394	CcSEcCtD
Trovafloxacin—Confusional state—Docetaxel—lung cancer	9.69e-05	0.000394	CcSEcCtD
Trovafloxacin—Photosensitivity reaction—Doxorubicin—lung cancer	9.62e-05	0.000391	CcSEcCtD
Trovafloxacin—Oedema—Docetaxel—lung cancer	9.61e-05	0.00039	CcSEcCtD
Trovafloxacin—Anaphylactic shock—Docetaxel—lung cancer	9.61e-05	0.00039	CcSEcCtD
Trovafloxacin—Weight increased—Doxorubicin—lung cancer	9.59e-05	0.00039	CcSEcCtD
Trovafloxacin—Pruritus—Gemcitabine—lung cancer	9.58e-05	0.000389	CcSEcCtD
Trovafloxacin—Weight decreased—Doxorubicin—lung cancer	9.54e-05	0.000388	CcSEcCtD
Trovafloxacin—Feeling abnormal—Etoposide—lung cancer	9.53e-05	0.000387	CcSEcCtD
Trovafloxacin—Hyperglycaemia—Doxorubicin—lung cancer	9.51e-05	0.000387	CcSEcCtD
Trovafloxacin—Diarrhoea—Irinotecan—lung cancer	9.51e-05	0.000386	CcSEcCtD
Trovafloxacin—Gastrointestinal pain—Etoposide—lung cancer	9.45e-05	0.000384	CcSEcCtD
Trovafloxacin—Shock—Docetaxel—lung cancer	9.45e-05	0.000384	CcSEcCtD
Trovafloxacin—TOP2A—Azacitidine—Gemcitabine—lung cancer	9.44e-05	0.0125	CbGdCrCtD
Trovafloxacin—Thrombocytopenia—Docetaxel—lung cancer	9.41e-05	0.000382	CcSEcCtD
Trovafloxacin—Visual impairment—Methotrexate—lung cancer	9.39e-05	0.000382	CcSEcCtD
Trovafloxacin—Tachycardia—Docetaxel—lung cancer	9.38e-05	0.000381	CcSEcCtD
Trovafloxacin—Feeling abnormal—Paclitaxel—lung cancer	9.34e-05	0.00038	CcSEcCtD
Trovafloxacin—Skin disorder—Docetaxel—lung cancer	9.33e-05	0.000379	CcSEcCtD
Trovafloxacin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	9.32e-05	0.000379	CcSEcCtD
Trovafloxacin—Hypersensitivity—Cisplatin—lung cancer	9.3e-05	0.000378	CcSEcCtD
Trovafloxacin—Gastrointestinal pain—Paclitaxel—lung cancer	9.27e-05	0.000377	CcSEcCtD
Trovafloxacin—Diarrhoea—Gemcitabine—lung cancer	9.26e-05	0.000376	CcSEcCtD
Trovafloxacin—Erythema multiforme—Methotrexate—lung cancer	9.21e-05	0.000375	CcSEcCtD
Trovafloxacin—Dizziness—Irinotecan—lung cancer	9.19e-05	0.000374	CcSEcCtD
Trovafloxacin—Urticaria—Etoposide—lung cancer	9.18e-05	0.000373	CcSEcCtD
Trovafloxacin—Stomatitis—Doxorubicin—lung cancer	9.16e-05	0.000372	CcSEcCtD
Trovafloxacin—Jaundice—Doxorubicin—lung cancer	9.16e-05	0.000372	CcSEcCtD
Trovafloxacin—Anorexia—Docetaxel—lung cancer	9.16e-05	0.000372	CcSEcCtD
Trovafloxacin—Body temperature increased—Etoposide—lung cancer	9.14e-05	0.000371	CcSEcCtD
Trovafloxacin—Abdominal pain—Etoposide—lung cancer	9.14e-05	0.000371	CcSEcCtD
Trovafloxacin—Conjunctivitis—Doxorubicin—lung cancer	9.14e-05	0.000371	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	9.09e-05	0.00405	CbGpPWpGaD
Trovafloxacin—Tinnitus—Methotrexate—lung cancer	9.09e-05	0.000369	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	9.06e-05	0.00404	CbGpPWpGaD
Trovafloxacin—Asthenia—Cisplatin—lung cancer	9.05e-05	0.000368	CcSEcCtD
Trovafloxacin—Urticaria—Paclitaxel—lung cancer	9e-05	0.000366	CcSEcCtD
Trovafloxacin—Hypotension—Docetaxel—lung cancer	8.98e-05	0.000365	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	8.97e-05	0.00399	CbGpPWpGaD
Trovafloxacin—Body temperature increased—Paclitaxel—lung cancer	8.96e-05	0.000364	CcSEcCtD
Trovafloxacin—Abdominal pain—Paclitaxel—lung cancer	8.96e-05	0.000364	CcSEcCtD
Trovafloxacin—Epistaxis—Doxorubicin—lung cancer	8.87e-05	0.00036	CcSEcCtD
Trovafloxacin—Vomiting—Irinotecan—lung cancer	8.84e-05	0.000359	CcSEcCtD
Trovafloxacin—Sinusitis—Doxorubicin—lung cancer	8.82e-05	0.000358	CcSEcCtD
Trovafloxacin—Agranulocytosis—Doxorubicin—lung cancer	8.77e-05	0.000357	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	8.77e-05	0.00391	CbGpPWpGaD
Trovafloxacin—Rash—Irinotecan—lung cancer	8.76e-05	0.000356	CcSEcCtD
Trovafloxacin—Dermatitis—Irinotecan—lung cancer	8.75e-05	0.000356	CcSEcCtD
Trovafloxacin—Musculoskeletal discomfort—Docetaxel—lung cancer	8.75e-05	0.000356	CcSEcCtD
Trovafloxacin—Chills—Methotrexate—lung cancer	8.74e-05	0.000355	CcSEcCtD
Trovafloxacin—Headache—Irinotecan—lung cancer	8.71e-05	0.000354	CcSEcCtD
Trovafloxacin—Insomnia—Docetaxel—lung cancer	8.69e-05	0.000353	CcSEcCtD
Trovafloxacin—Diarrhoea—Cisplatin—lung cancer	8.63e-05	0.000351	CcSEcCtD
Trovafloxacin—Paraesthesia—Docetaxel—lung cancer	8.63e-05	0.000351	CcSEcCtD
Trovafloxacin—Vomiting—Gemcitabine—lung cancer	8.61e-05	0.00035	CcSEcCtD
Trovafloxacin—Bradycardia—Doxorubicin—lung cancer	8.59e-05	0.000349	CcSEcCtD
Trovafloxacin—Dyspnoea—Docetaxel—lung cancer	8.56e-05	0.000348	CcSEcCtD
Trovafloxacin—Somnolence—Docetaxel—lung cancer	8.54e-05	0.000347	CcSEcCtD
Trovafloxacin—Rash—Gemcitabine—lung cancer	8.54e-05	0.000347	CcSEcCtD
Trovafloxacin—Dermatitis—Gemcitabine—lung cancer	8.53e-05	0.000347	CcSEcCtD
Trovafloxacin—Hypersensitivity—Etoposide—lung cancer	8.52e-05	0.000346	CcSEcCtD
Trovafloxacin—Haemoglobin—Doxorubicin—lung cancer	8.48e-05	0.000345	CcSEcCtD
Trovafloxacin—Headache—Gemcitabine—lung cancer	8.48e-05	0.000345	CcSEcCtD
Trovafloxacin—Rhinitis—Doxorubicin—lung cancer	8.46e-05	0.000344	CcSEcCtD
Trovafloxacin—Dyspepsia—Docetaxel—lung cancer	8.46e-05	0.000344	CcSEcCtD
Trovafloxacin—Hepatitis—Doxorubicin—lung cancer	8.44e-05	0.000343	CcSEcCtD
Trovafloxacin—Haemorrhage—Doxorubicin—lung cancer	8.44e-05	0.000343	CcSEcCtD
Trovafloxacin—Hypoaesthesia—Doxorubicin—lung cancer	8.4e-05	0.000341	CcSEcCtD
Trovafloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—lung cancer	8.39e-05	0.00374	CbGpPWpGaD
Trovafloxacin—Decreased appetite—Docetaxel—lung cancer	8.35e-05	0.000339	CcSEcCtD
Trovafloxacin—Hypersensitivity—Paclitaxel—lung cancer	8.35e-05	0.000339	CcSEcCtD
Trovafloxacin—Oedema peripheral—Doxorubicin—lung cancer	8.31e-05	0.000338	CcSEcCtD
Trovafloxacin—Dysgeusia—Methotrexate—lung cancer	8.31e-05	0.000338	CcSEcCtD
Trovafloxacin—Gastrointestinal disorder—Docetaxel—lung cancer	8.29e-05	0.000337	CcSEcCtD
Trovafloxacin—Asthenia—Etoposide—lung cancer	8.29e-05	0.000337	CcSEcCtD
Trovafloxacin—Fatigue—Docetaxel—lung cancer	8.28e-05	0.000337	CcSEcCtD
Trovafloxacin—Nausea—Irinotecan—lung cancer	8.25e-05	0.000336	CcSEcCtD
Trovafloxacin—Pain—Docetaxel—lung cancer	8.21e-05	0.000334	CcSEcCtD
Trovafloxacin—Constipation—Docetaxel—lung cancer	8.21e-05	0.000334	CcSEcCtD
Trovafloxacin—Back pain—Methotrexate—lung cancer	8.21e-05	0.000334	CcSEcCtD
Trovafloxacin—Pruritus—Etoposide—lung cancer	8.18e-05	0.000332	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	8.14e-05	0.00363	CbGpPWpGaD
Trovafloxacin—Visual impairment—Doxorubicin—lung cancer	8.13e-05	0.000331	CcSEcCtD
Trovafloxacin—Asthenia—Paclitaxel—lung cancer	8.13e-05	0.000331	CcSEcCtD
Trovafloxacin—Nausea—Gemcitabine—lung cancer	8.04e-05	0.000327	CcSEcCtD
Trovafloxacin—Vomiting—Cisplatin—lung cancer	8.02e-05	0.000326	CcSEcCtD
Trovafloxacin—Pruritus—Paclitaxel—lung cancer	8.02e-05	0.000326	CcSEcCtD
Trovafloxacin—Erythema multiforme—Doxorubicin—lung cancer	7.98e-05	0.000324	CcSEcCtD
Trovafloxacin—Rash—Cisplatin—lung cancer	7.96e-05	0.000323	CcSEcCtD
Trovafloxacin—Dermatitis—Cisplatin—lung cancer	7.95e-05	0.000323	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	7.92e-05	0.00353	CbGpPWpGaD
Trovafloxacin—Feeling abnormal—Docetaxel—lung cancer	7.92e-05	0.000322	CcSEcCtD
Trovafloxacin—Diarrhoea—Etoposide—lung cancer	7.91e-05	0.000321	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	7.9e-05	0.00352	CbGpPWpGaD
Trovafloxacin—Ill-defined disorder—Methotrexate—lung cancer	7.87e-05	0.00032	CcSEcCtD
Trovafloxacin—Tinnitus—Doxorubicin—lung cancer	7.87e-05	0.00032	CcSEcCtD
Trovafloxacin—Gastrointestinal pain—Docetaxel—lung cancer	7.86e-05	0.000319	CcSEcCtD
Trovafloxacin—Anaemia—Methotrexate—lung cancer	7.84e-05	0.000319	CcSEcCtD
Trovafloxacin—Flushing—Doxorubicin—lung cancer	7.83e-05	0.000318	CcSEcCtD
Trovafloxacin—Diarrhoea—Paclitaxel—lung cancer	7.75e-05	0.000315	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	7.66e-05	0.00341	CbGpPWpGaD
Trovafloxacin—Malaise—Methotrexate—lung cancer	7.65e-05	0.000311	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	7.65e-05	0.00341	CbGpPWpGaD
Trovafloxacin—Dizziness—Etoposide—lung cancer	7.64e-05	0.000311	CcSEcCtD
Trovafloxacin—Vertigo—Methotrexate—lung cancer	7.62e-05	0.00031	CcSEcCtD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—lung cancer	7.62e-05	0.00339	CbGpPWpGaD
Trovafloxacin—Body temperature increased—Docetaxel—lung cancer	7.59e-05	0.000309	CcSEcCtD
Trovafloxacin—Abdominal pain—Docetaxel—lung cancer	7.59e-05	0.000309	CcSEcCtD
Trovafloxacin—Leukopenia—Methotrexate—lung cancer	7.59e-05	0.000309	CcSEcCtD
Trovafloxacin—TOP2A—Circadian rythm related genes—JUN—lung cancer	7.59e-05	0.00338	CbGpPWpGaD
Trovafloxacin—Chills—Doxorubicin—lung cancer	7.57e-05	0.000308	CcSEcCtD
Trovafloxacin—Dizziness—Paclitaxel—lung cancer	7.49e-05	0.000305	CcSEcCtD
Trovafloxacin—Nausea—Cisplatin—lung cancer	7.49e-05	0.000305	CcSEcCtD
Trovafloxacin—Cough—Methotrexate—lung cancer	7.4e-05	0.000301	CcSEcCtD
Trovafloxacin—Convulsion—Methotrexate—lung cancer	7.35e-05	0.000299	CcSEcCtD
Trovafloxacin—Vomiting—Etoposide—lung cancer	7.35e-05	0.000299	CcSEcCtD
Trovafloxacin—TOP2A—Circadian rythm related genes—PTEN—lung cancer	7.34e-05	0.00327	CbGpPWpGaD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	7.29e-05	0.00325	CbGpPWpGaD
Trovafloxacin—Rash—Etoposide—lung cancer	7.29e-05	0.000296	CcSEcCtD
Trovafloxacin—Dermatitis—Etoposide—lung cancer	7.28e-05	0.000296	CcSEcCtD
Trovafloxacin—Headache—Etoposide—lung cancer	7.24e-05	0.000294	CcSEcCtD
Trovafloxacin—Flatulence—Doxorubicin—lung cancer	7.24e-05	0.000294	CcSEcCtD
Trovafloxacin—Myalgia—Methotrexate—lung cancer	7.22e-05	0.000294	CcSEcCtD
Trovafloxacin—Chest pain—Methotrexate—lung cancer	7.22e-05	0.000294	CcSEcCtD
Trovafloxacin—Arthralgia—Methotrexate—lung cancer	7.22e-05	0.000294	CcSEcCtD
Trovafloxacin—Tension—Doxorubicin—lung cancer	7.21e-05	0.000293	CcSEcCtD
Trovafloxacin—Vomiting—Paclitaxel—lung cancer	7.21e-05	0.000293	CcSEcCtD
Trovafloxacin—Dysgeusia—Doxorubicin—lung cancer	7.19e-05	0.000292	CcSEcCtD
Trovafloxacin—Rash—Paclitaxel—lung cancer	7.15e-05	0.00029	CcSEcCtD
Trovafloxacin—Dermatitis—Paclitaxel—lung cancer	7.14e-05	0.00029	CcSEcCtD
Trovafloxacin—Discomfort—Methotrexate—lung cancer	7.14e-05	0.00029	CcSEcCtD
Trovafloxacin—Nervousness—Doxorubicin—lung cancer	7.13e-05	0.00029	CcSEcCtD
Trovafloxacin—Back pain—Doxorubicin—lung cancer	7.11e-05	0.000289	CcSEcCtD
Trovafloxacin—Headache—Paclitaxel—lung cancer	7.1e-05	0.000289	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	7.09e-05	0.00316	CbGpPWpGaD
Trovafloxacin—Hypersensitivity—Docetaxel—lung cancer	7.08e-05	0.000288	CcSEcCtD
Trovafloxacin—Muscle spasms—Doxorubicin—lung cancer	7.06e-05	0.000287	CcSEcCtD
Trovafloxacin—TOP2A—Circadian rythm related genes—EP300—lung cancer	7e-05	0.00312	CbGpPWpGaD
Trovafloxacin—Confusional state—Methotrexate—lung cancer	6.98e-05	0.000284	CcSEcCtD
Trovafloxacin—Anaphylactic shock—Methotrexate—lung cancer	6.92e-05	0.000281	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	6.91e-05	0.00308	CbGpPWpGaD
Trovafloxacin—Asthenia—Docetaxel—lung cancer	6.89e-05	0.00028	CcSEcCtD
Trovafloxacin—Nausea—Etoposide—lung cancer	6.87e-05	0.000279	CcSEcCtD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—lung cancer	6.85e-05	0.00305	CbGpPWpGaD
Trovafloxacin—Ill-defined disorder—Doxorubicin—lung cancer	6.82e-05	0.000277	CcSEcCtD
Trovafloxacin—TOP2A—Cell Cycle—TYMS—lung cancer	6.81e-05	0.00303	CbGpPWpGaD
Trovafloxacin—Pruritus—Docetaxel—lung cancer	6.8e-05	0.000276	CcSEcCtD
Trovafloxacin—Anaemia—Doxorubicin—lung cancer	6.79e-05	0.000276	CcSEcCtD
Trovafloxacin—Thrombocytopenia—Methotrexate—lung cancer	6.78e-05	0.000276	CcSEcCtD
Trovafloxacin—Agitation—Doxorubicin—lung cancer	6.75e-05	0.000274	CcSEcCtD
Trovafloxacin—Nausea—Paclitaxel—lung cancer	6.73e-05	0.000274	CcSEcCtD
Trovafloxacin—Skin disorder—Methotrexate—lung cancer	6.73e-05	0.000273	CcSEcCtD
Trovafloxacin—Hyperhidrosis—Methotrexate—lung cancer	6.69e-05	0.000272	CcSEcCtD
Trovafloxacin—Malaise—Doxorubicin—lung cancer	6.62e-05	0.000269	CcSEcCtD
Trovafloxacin—Vertigo—Doxorubicin—lung cancer	6.6e-05	0.000268	CcSEcCtD
Trovafloxacin—Anorexia—Methotrexate—lung cancer	6.6e-05	0.000268	CcSEcCtD
Trovafloxacin—Syncope—Doxorubicin—lung cancer	6.59e-05	0.000268	CcSEcCtD
Trovafloxacin—Leukopenia—Doxorubicin—lung cancer	6.58e-05	0.000267	CcSEcCtD
Trovafloxacin—Diarrhoea—Docetaxel—lung cancer	6.57e-05	0.000267	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	6.53e-05	0.00291	CbGpPWpGaD
Trovafloxacin—Palpitations—Doxorubicin—lung cancer	6.49e-05	0.000264	CcSEcCtD
Trovafloxacin—Hypotension—Methotrexate—lung cancer	6.47e-05	0.000263	CcSEcCtD
Trovafloxacin—Loss of consciousness—Doxorubicin—lung cancer	6.46e-05	0.000262	CcSEcCtD
Trovafloxacin—Cough—Doxorubicin—lung cancer	6.41e-05	0.000261	CcSEcCtD
Trovafloxacin—Convulsion—Doxorubicin—lung cancer	6.36e-05	0.000259	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	6.35e-05	0.00283	CbGpPWpGaD
Trovafloxacin—Dizziness—Docetaxel—lung cancer	6.35e-05	0.000258	CcSEcCtD
Trovafloxacin—Hypertension—Doxorubicin—lung cancer	6.34e-05	0.000258	CcSEcCtD
Trovafloxacin—Musculoskeletal discomfort—Methotrexate—lung cancer	6.31e-05	0.000256	CcSEcCtD
Trovafloxacin—Insomnia—Methotrexate—lung cancer	6.26e-05	0.000255	CcSEcCtD
Trovafloxacin—Arthralgia—Doxorubicin—lung cancer	6.25e-05	0.000254	CcSEcCtD
Trovafloxacin—Myalgia—Doxorubicin—lung cancer	6.25e-05	0.000254	CcSEcCtD
Trovafloxacin—Chest pain—Doxorubicin—lung cancer	6.25e-05	0.000254	CcSEcCtD
Trovafloxacin—Anxiety—Doxorubicin—lung cancer	6.23e-05	0.000253	CcSEcCtD
Trovafloxacin—Paraesthesia—Methotrexate—lung cancer	6.22e-05	0.000253	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	6.21e-05	0.00277	CbGpPWpGaD
Trovafloxacin—Discomfort—Doxorubicin—lung cancer	6.18e-05	0.000251	CcSEcCtD
Trovafloxacin—Dyspnoea—Methotrexate—lung cancer	6.17e-05	0.000251	CcSEcCtD
Trovafloxacin—Somnolence—Methotrexate—lung cancer	6.16e-05	0.00025	CcSEcCtD
Trovafloxacin—TOP2A—Cell Cycle—BIRC5—lung cancer	6.12e-05	0.00273	CbGpPWpGaD
Trovafloxacin—Dry mouth—Doxorubicin—lung cancer	6.12e-05	0.000249	CcSEcCtD
Trovafloxacin—Vomiting—Docetaxel—lung cancer	6.11e-05	0.000248	CcSEcCtD
Trovafloxacin—Dyspepsia—Methotrexate—lung cancer	6.09e-05	0.000248	CcSEcCtD
Trovafloxacin—Rash—Docetaxel—lung cancer	6.06e-05	0.000246	CcSEcCtD
Trovafloxacin—Dermatitis—Docetaxel—lung cancer	6.05e-05	0.000246	CcSEcCtD
Trovafloxacin—Confusional state—Doxorubicin—lung cancer	6.05e-05	0.000246	CcSEcCtD
Trovafloxacin—Decreased appetite—Methotrexate—lung cancer	6.02e-05	0.000245	CcSEcCtD
Trovafloxacin—Headache—Docetaxel—lung cancer	6.02e-05	0.000245	CcSEcCtD
Trovafloxacin—Anaphylactic shock—Doxorubicin—lung cancer	6e-05	0.000244	CcSEcCtD
Trovafloxacin—Oedema—Doxorubicin—lung cancer	6e-05	0.000244	CcSEcCtD
Trovafloxacin—Gastrointestinal disorder—Methotrexate—lung cancer	5.98e-05	0.000243	CcSEcCtD
Trovafloxacin—Fatigue—Methotrexate—lung cancer	5.97e-05	0.000243	CcSEcCtD
Trovafloxacin—TOP2A—Cell Cycle—TERT—lung cancer	5.93e-05	0.00264	CbGpPWpGaD
Trovafloxacin—Pain—Methotrexate—lung cancer	5.92e-05	0.000241	CcSEcCtD
Trovafloxacin—Shock—Doxorubicin—lung cancer	5.9e-05	0.00024	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	5.87e-05	0.00262	CbGpPWpGaD
Trovafloxacin—Thrombocytopenia—Doxorubicin—lung cancer	5.87e-05	0.000239	CcSEcCtD
Trovafloxacin—Tachycardia—Doxorubicin—lung cancer	5.85e-05	0.000238	CcSEcCtD
Trovafloxacin—Skin disorder—Doxorubicin—lung cancer	5.82e-05	0.000237	CcSEcCtD
Trovafloxacin—Hyperhidrosis—Doxorubicin—lung cancer	5.8e-05	0.000236	CcSEcCtD
Trovafloxacin—Anorexia—Doxorubicin—lung cancer	5.71e-05	0.000232	CcSEcCtD
Trovafloxacin—Nausea—Docetaxel—lung cancer	5.71e-05	0.000232	CcSEcCtD
Trovafloxacin—Feeling abnormal—Methotrexate—lung cancer	5.71e-05	0.000232	CcSEcCtD
Trovafloxacin—Gastrointestinal pain—Methotrexate—lung cancer	5.66e-05	0.00023	CcSEcCtD
Trovafloxacin—Hypotension—Doxorubicin—lung cancer	5.6e-05	0.000228	CcSEcCtD
Trovafloxacin—Urticaria—Methotrexate—lung cancer	5.5e-05	0.000224	CcSEcCtD
Trovafloxacin—Abdominal pain—Methotrexate—lung cancer	5.47e-05	0.000222	CcSEcCtD
Trovafloxacin—Body temperature increased—Methotrexate—lung cancer	5.47e-05	0.000222	CcSEcCtD
Trovafloxacin—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.46e-05	0.000222	CcSEcCtD
Trovafloxacin—Insomnia—Doxorubicin—lung cancer	5.42e-05	0.00022	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	5.39e-05	0.0024	CbGpPWpGaD
Trovafloxacin—Paraesthesia—Doxorubicin—lung cancer	5.38e-05	0.000219	CcSEcCtD
Trovafloxacin—Dyspnoea—Doxorubicin—lung cancer	5.35e-05	0.000217	CcSEcCtD
Trovafloxacin—Somnolence—Doxorubicin—lung cancer	5.33e-05	0.000217	CcSEcCtD
Trovafloxacin—Dyspepsia—Doxorubicin—lung cancer	5.28e-05	0.000215	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	5.22e-05	0.00232	CbGpPWpGaD
Trovafloxacin—Decreased appetite—Doxorubicin—lung cancer	5.21e-05	0.000212	CcSEcCtD
Trovafloxacin—Gastrointestinal disorder—Doxorubicin—lung cancer	5.18e-05	0.00021	CcSEcCtD
Trovafloxacin—Fatigue—Doxorubicin—lung cancer	5.17e-05	0.00021	CcSEcCtD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—RB1—lung cancer	5.16e-05	0.0023	CbGpPWpGaD
Trovafloxacin—Pain—Doxorubicin—lung cancer	5.13e-05	0.000208	CcSEcCtD
Trovafloxacin—Constipation—Doxorubicin—lung cancer	5.13e-05	0.000208	CcSEcCtD
Trovafloxacin—Hypersensitivity—Methotrexate—lung cancer	5.1e-05	0.000207	CcSEcCtD
Trovafloxacin—TOP2A—Circadian rythm related genes—TP53—lung cancer	5.01e-05	0.00223	CbGpPWpGaD
Trovafloxacin—Asthenia—Methotrexate—lung cancer	4.97e-05	0.000202	CcSEcCtD
Trovafloxacin—Feeling abnormal—Doxorubicin—lung cancer	4.94e-05	0.000201	CcSEcCtD
Trovafloxacin—Gastrointestinal pain—Doxorubicin—lung cancer	4.9e-05	0.000199	CcSEcCtD
Trovafloxacin—Pruritus—Methotrexate—lung cancer	4.9e-05	0.000199	CcSEcCtD
Trovafloxacin—Urticaria—Doxorubicin—lung cancer	4.76e-05	0.000194	CcSEcCtD
Trovafloxacin—Body temperature increased—Doxorubicin—lung cancer	4.74e-05	0.000193	CcSEcCtD
Trovafloxacin—Abdominal pain—Doxorubicin—lung cancer	4.74e-05	0.000193	CcSEcCtD
Trovafloxacin—Diarrhoea—Methotrexate—lung cancer	4.74e-05	0.000193	CcSEcCtD
Trovafloxacin—TOP2A—Cell Cycle—RB1—lung cancer	4.62e-05	0.00206	CbGpPWpGaD
Trovafloxacin—TOP2A—Circadian rythm related genes—IL6—lung cancer	4.58e-05	0.00204	CbGpPWpGaD
Trovafloxacin—Dizziness—Methotrexate—lung cancer	4.58e-05	0.000186	CcSEcCtD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—lung cancer	4.54e-05	0.00202	CbGpPWpGaD
Trovafloxacin—Hypersensitivity—Doxorubicin—lung cancer	4.42e-05	0.00018	CcSEcCtD
Trovafloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	4.41e-05	0.00196	CbGpPWpGaD
Trovafloxacin—Vomiting—Methotrexate—lung cancer	4.4e-05	0.000179	CcSEcCtD
Trovafloxacin—Rash—Methotrexate—lung cancer	4.37e-05	0.000177	CcSEcCtD
Trovafloxacin—Dermatitis—Methotrexate—lung cancer	4.36e-05	0.000177	CcSEcCtD
Trovafloxacin—Headache—Methotrexate—lung cancer	4.34e-05	0.000176	CcSEcCtD
Trovafloxacin—Asthenia—Doxorubicin—lung cancer	4.3e-05	0.000175	CcSEcCtD
Trovafloxacin—Pruritus—Doxorubicin—lung cancer	4.24e-05	0.000172	CcSEcCtD
Trovafloxacin—Nausea—Methotrexate—lung cancer	4.11e-05	0.000167	CcSEcCtD
Trovafloxacin—Diarrhoea—Doxorubicin—lung cancer	4.1e-05	0.000167	CcSEcCtD
Trovafloxacin—TOP2A—Cell Cycle—CDKN2A—lung cancer	4.06e-05	0.00181	CbGpPWpGaD
Trovafloxacin—Dizziness—Doxorubicin—lung cancer	3.96e-05	0.000161	CcSEcCtD
Trovafloxacin—TOP2A—Cell Cycle—MDM2—lung cancer	3.94e-05	0.00175	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—lung cancer	3.83e-05	0.00171	CbGpPWpGaD
Trovafloxacin—Vomiting—Doxorubicin—lung cancer	3.81e-05	0.000155	CcSEcCtD
Trovafloxacin—Rash—Doxorubicin—lung cancer	3.78e-05	0.000154	CcSEcCtD
Trovafloxacin—Dermatitis—Doxorubicin—lung cancer	3.78e-05	0.000154	CcSEcCtD
Trovafloxacin—Headache—Doxorubicin—lung cancer	3.76e-05	0.000153	CcSEcCtD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—lung cancer	3.71e-05	0.00165	CbGpPWpGaD
Trovafloxacin—Nausea—Doxorubicin—lung cancer	3.56e-05	0.000145	CcSEcCtD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—EP300—lung cancer	3.53e-05	0.00157	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—CCND1—lung cancer	3.43e-05	0.00153	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—CDKN1A—lung cancer	3.32e-05	0.00148	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—lung cancer	3.16e-05	0.00141	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—EP300—lung cancer	3.16e-05	0.00141	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle, Mitotic—MYC—lung cancer	3.08e-05	0.00137	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—MAPK3—lung cancer	2.83e-05	0.00126	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—MYC—lung cancer	2.75e-05	0.00123	CbGpPWpGaD
Trovafloxacin—TOP2A—Cell Cycle—TP53—lung cancer	2.26e-05	0.00101	CbGpPWpGaD
